Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14806869 | 1.00 | MAOA (0.40) | MAOAMAOBPRSS1HRH3HDAC1 | |
| SCHEMBL14806861 | 0.99 | MAOA (0.39) | MAOAMAOBPRSS1HRH3HDAC1 | |
| SCHEMBL584885 | 0.87 | TSHR (0.50) | CYP1A2CYP19A1CYP2C9CYP2C19TSHR | |
| SCHEMBL8909566 | 0.84 | NOS3 (0.40) | PRSS1CYP1A2CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL585273 | 0.82 | MAOA (0.34) | MAOAMAOBCYP1A2CYP19A1CYP2C9 | |
| SCHEMBL585410 | 0.81 | TSHR (0.44) | CYP1A2CYP19A1CYP2C9CYP2C19TSHR | |
| SCHEMBL2199999 | 0.81 | TSHR (0.44) | CYP1A2CYP19A1CYP2C9CYP2C19TSHR | |
| SCHEMBL14806868 | 0.81 | TSHR (0.44) | MAOAHRH3CYP1A2CYP19A1CYP2C9 | |
| SCHEMBL14806866 | 0.81 | CHRNA7 (0.44) | HRH3 | |
| SCHEMBL27793466 | 0.78 | LSS (0.40) | HRH3HDAC1HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2759546-B1 | METALLOPORPHYRIN COMPLEX, MANUFACTURING PROCESS THEREFOR AND ITS USE AS CARBON DIOXIDE FIXATION CATALYST, AS WELL AS PROCESS FOR MANUFACTURING CYCLIC CARBONATE | NAT UNIV CORPORATION OKAYAMA UNIV (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-9211534-B2 | Metalloporphyrin complex, manufacturing process therefor and carbon dioxide fixation catalyst therefrom, as well as process for manufacturing cyclic carbonate | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2015-12-15 | — | — | US | disclosed |
| US-20140228561-A1 | METALLOPORPHYRIN COMPLEX, MANUFACTURING PROCESS THEREFOR AND CARBON DIOXIDE FIXATION CATALYST THEREFROM, AS WELL AS PROCESS FOR MANUFACTURING CYCLIC CARBONATE | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2014-08-14 | — | — | US | disclosed |
| CN-103987714-A | Metal porphyrin complex, method for producing same, carbon dioxide immobilization catalyst comprising same, and method for producing cyclic carbonic acid ester. | UNIV OKAYAMA NAT UNIV CORP | 2014-08-13 | — | — | CN | disclosed |
| EP-2759546-A1 | METAL PORPHYRIN COMPLEX, METHOD FOR PRODUCING SAME, CARBON DIOXIDE IMMOBILIZATION CATALYST COMPRISING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONIC ACID ESTER. | National University Corporation Okayama University (JP) | 2014-07-30 | — | — | EP | disclosed |
| WO-2013042695-A1 | METAL PORPHYRIN COMPLEX, METHOD FOR PRODUCING SAME, CARBON DIOXIDE IMMOBILIZATION CATALYST COMPRISING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONIC ACID ESTER. | 国立大学法人岡山大学 (JP) | 2013-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140228561-A1 | METALLOPORPHYRIN COMPLEX, MANUFACTURING PROCESS THEREFOR AND CARBON DIOXIDE FIXATION CATALYST THEREFROM, AS WELL AS PROCESS FOR MANUFACTURING CYCLIC CARBONATE | CYP4F11, CYP4F2, CYP4F12 | MAOA 3058/4885MAOB 3231/4885PRSS1 2112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.